A proton-pump inhibitor called omeprazole, which should only affect the NLRP3 inflammasome activation portion of this signalling axis, was effective in ameliorating CIN and decreasing TLR4/NF-κB/NLRP3 levels. This evidence concerns the gene NFKB1 and cervical squamous intraepithelial neoplasia.